Augmented reality (AR) may be a useful tool for the delivery of dual-task training. This manuscript details the development of the Dual-task Augmented Reality Treatment (DART) platform for individuals with Parkinson’s disease (PD) and reports initial feasibility, usability, and efficacy of the DART platform in provoking dual-task interference in individuals with PD. The DART platform utilizes the head-mounted Microsoft HoloLens2 AR device to deliver concurrent motor and cognitive tasks. Biomechanical metrics of gait and cognitive responses are automatically computed and provided to the supervising clinician. To assess feasibility, individuals with PD (N = 48) completed a bout of single-task and dual-task walking using the DART platform. Usability was assessed by the System Usability Scale (SUS). Dual-task interference was assessed by comparing single-task walking and walking during an obstacle course while performing a cognitive task. Average gait velocity decreased from 1.06 to 0.82 m/s from single- to dual-task conditions. Mean SUS scores were 81.3 (11.3), which placed the DART in the “good” to “excellent” category. To our knowledge, the DART platform is the first to use a head-mounted AR system to deliver a dual-task paradigm and simultaneously provide biomechanical data that characterize cognitive and motor performance. Individuals with PD were able to successfully use the DART platform with satisfaction, and dual-task interference was provoked. The DART platform should be investigated as a platform to treat dual-task declines associated with PD.
Background/Objectives: Technological approaches for the objective, quantitative assessment of motor functions have the potential to improve the medical management of people with Parkinson’s disease (PwPD), offering more precise, data-driven insights to enhance diagnosis, monitoring, and treatment. Markerless motion capture (MMC) is a promising approach for the integration of biomechanical analysis into clinical practice. The aims of this project were to evaluate a commercially available MMC system, develop and validate a custom MMC data processing algorithm, and evaluate the effectiveness of the algorithm in discriminating fine motor performance between PwPD and healthy controls (HCs). Methods: A total of 58 PwPD and 25 HCs completed finger-tapping assessments, administered and recorded by a self-worn augmented reality headset. Fine motor performance was evaluated using the headset’s built-in hand tracking software (Native-MMC) and a custom algorithm (CART-MMC). Outcomes from each were compared against a gold-standard motion capture system (Traditional-MC) to determine the equivalence. Known-group validity was evaluated using CART-MMC. Results: A total of 82 trials were analyzed for equivalence against the Traditional-MC, and 152 trials were analyzed for known-group validity. The CART-MMC outcomes were statistically equivalent to Traditional-MC (within 5%) for tap count, frequency, amplitude, and opening velocity metrics. The Native-MMC did not meet equivalence with the Traditional-MC, deviating by an average of 24% across all outcomes. The CART-MMC captured significant differences between PwPD and HCs for tapping amplitude, amplitude variability, frequency variability, finger opening and closing velocities, and their respective variabilities, and normalized path length. Conclusions: The biomechanical data gathered using a commercially available augmented reality device and analyzed via a custom algorithm accurately characterize fine motor performance in PwPD.
Background: Stair ambulation is a complex motor task that presents a substantial fall risk for people with Parkinson’s disease (PwPD) who often have postural instability and gait difficulty (PIGD) and experience unpredictable freezing of gait (FOG) episodes. While dual-task (DT) interference during level walking is well-documented, its impact on stair ambulation, an everyday, high-risk activity, remains poorly understood. Objective: The aim of this study was to quantify the impact of dual tasking on patterns of motor control during stair ambulation using kinetic data from The Stair Ambulation and Functional Evaluation of Gait (Safe-Gait) system. Methods: Seventeen individuals with Parkinson’s disease (PD) completed three single-task (ST) and three dual-task (DT) trials on the Safe-Gait system, which sampled kinetic data via embedded force plates during stair ascent and descent. The force plate data were used to quantify step time, braking and propulsive impulses, and center of pressure (CoP) displacement and sway speed to assess DT effects on stair ambulation kinetics. Results: Dual-task conditions led to significant increases in step time (p < 0.001), braking impulse (p < 0.01), anteroposterior center of pressure (CoP) range (p < 0.05), and a decrease in mediolateral CoP speed (p < 0.01). Conclusions: Dual tasking during stair ambulation altered gait kinetics in PwPD, evidenced by slower, less stable movement patterns. These findings highlight the impact of cognitive motor DT interference on functional mobility and support the use of instrumented stair assessments to guide therapeutic care and fall risk interventions.
Subjective, imprecise evaluation of lower extremity function hinders the effective treatment of gait impairments in Parkinson’s disease (PD). Markerless motion capture (MMC) offers opportunities for integrating objective biomechanical outcomes into clinical practice. However, validation of MMC biomechanical outcomes is necessary for clinical adoption of MMC technologies. This project evaluated the criterion validity of a custom MMC algorithm (CART-MMC) against gold-standard 3D motion capture (Traditional-MC) and its known-groups validity in differentiating PD from healthy controls (HC). Sixty-two individuals with PD and 29 HCs completed a stepping in place paradigm. The trials were recorded by an augmented reality headset with embedded RGB and depth cameras. The CART-MMC algorithm was used to reconstruct a 3D pose model and compute biomechanical measures of lower extremity performance. CART-MMC outcomes were statistically equivalent, within 5% of Traditional-MC, for measures of step count, cadence, duration, height, height asymmetry, and normalized path length. CART-MMC captured significant between-group differences in step height, height variability, height asymmetry, duration variability, and normalized path length. In conclusion, CART-MMC provides valid biomechanical outcomes that characterize important domains of PD lower extremity function. Validated biomechanical evaluation tools present opportunities for tracking subtle changes in disease progression, informing targeted therapy, and monitoring treatment efficacy.
Background/Objectives: Falls have devastating consequences for older adults. The Functional Ambulation and Stair Test (FAST) was developed to characterize older adult mobility and eventual fall risk. This project aimed to determine the criterion validity of the FAST assessment by comparing the relationship between FAST outcomes and existing gold-standard clinical assessments of mobility and fall risk. A secondary aim was assessing the FAST’s capacity to elicit dual-task effects in older adults. Methods: The FAST is a multi-faceted mobility assessment combining stair navigation, turning and level-ground walking; total time and time spent in each phase are the calculated outcomes. Data from 199 older adults completing the FAST, Berg Balance Scale (BBS), Timed Up and Go (TUG), and Ten Meter Walk Test (10MWT) at comfortable and fast speed were evaluated. Relationships between the FAST and clinical outcomes were evaluated with Spearman’s correlations. The FAST and TUG were assessed under single- and dual-task conditions; linear mixed models evaluated the dual-task effects for overall FAST time and each phase. Results: Spearman’s correlations between the FAST and the BBS, TUG, 10MWT comfortable and 10MWT fast were −0.65, 0.88, −0.79, and −0.83, respectively. Participants experienced an 8.6% and 13.2% dual-task cost in the FAST and TUG, respectively. The greatest dual-task cost during the FAST was in the gait initiation, walking, and wide turn phases. Conclusions: Agreement between the FAST and gold-standard clinical mobility assessments confirms the criterion validity of the FAST. Delineation of mobility phases via the FAST offers insight into specific mobility deficits. Future work is ongoing to evaluate the FAST as a fall risk assessment in older adults.